Abstract Details

Transcranial Direct Current Stimulation (tDCS) can Enhance Physical Training Outcomes in Multiple Sclerosis (MS)
Multiple Sclerosis
P6 - Poster Session 6 (11:30 AM-1:00 PM)
9-024

tDCS is a non-invasive brain stimulation technique that is believed to exert clinical benefits through modulation of cortical excitability and plasticity, thereby enhancing and prolonging training gains. While tDCS has been increasingly studied for the reduction of severity of MS symptoms such as cognitive impairment, fatigue, and spasticity with promising results, its potential for improving motor deficits have been understudied. We address this gap by investigating the synergistic effects of tDCS combined with physical activity.

To determine the effect of multiple sessions of transcranial direct current stimulation (tDCS) combined with aerobic physical activity on balance and walking in patients with multiple sclerosis (MS).

MS participants (EDSS<6.5) are recruited for an ongoing randomized controlled trial to receive 10 sessions of either active or sham tDCS paired with unloaded cycling for 20 minutes. Stimulation is administered over the primary motor cortex (2.5 mA; anode over C3/cathode over FP2).  The primary outcome is walking ability, endurance, and static balance quantitatively assessed using a single inertial sensor placed on the lower back (gait and 2 minutes walking test) and a force platform (postural sway). Measurements are collected at baseline, at the end of tDCS intervention, and 4-weeks post-intervention.

A male 59 year-old-patient (secondary progressive subtype; EDSS: 5.5) completed the full 10 sessions. Compared to baseline visit, the participant showed improvement in gait speed (from 1.16 to 1.35 m/s) and stride length (from 1.12 to 1.46 m). Similarly, there was a reduction of 30% in sway area and an increase of 35% in the overall distance walked over 2 minutes. Lingering benefits were observed at 4-weeks following tDCS treatment. Full results from the study will be included at the time of presentation.

Our preliminary results showed cumulative and long-lasting benefits of multiple sessions of tDCS combined with physical activity on motor functions.

Authors/Disclosures
Giuseppina Pilloni, PhD (NYU Grossman School of Medicine) Dr. Pilloni has nothing to disclose.
Claire Sunha Choi, MD Ms. Choi has nothing to disclose.
Michael Shaw Mr. Shaw has nothing to disclose.
Kathleen Sherman (NYU Langone Health, MS Comprehensive Care Center) An immediate family member of Ms. Sherman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Total Solutions. An immediate family member of Ms. Sherman has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for APA.
No disclosure on file
Lauren B. Krupp, MD, FAAN (NYU Langone Medical Center) Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medscape. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EBIX. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffman LaRoche. Dr. krupp has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for MMMK. Dr. krupp has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Patrick, Dolan, and Kaufman. Dr. krupp has received intellectual property interests from a discovery or technology relating to health care.
Leigh E. Charvet, PhD (NYU Langone) Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Johnson & Johnson. Dr. Charvet has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Springer Healthcare. Dr. Charvet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for YBrain. Dr. Charvet has stock in Johnson&Johnson.